FDA Label for Curatussin
View Indications, Usage & Precautions
Curatussin Product Label
The following document was submitted to the FDA by the labeler of this product Wittman Pharma, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Dosage & Admin
Directions:
■ do not take more than 6 doses in any 24-hour period.
AGE | DOSE |
Adults & Children 12 years and over | 2-4 teaspoonfuls every 4 hours |
Children 6 years to under 12 years | 1-2 teaspoonfuls every 4 hours |
Children 2 to under 6 years | 1/2 - 1 teaspoonfuls every 4 hours |
Children Under 2 years | Ask a Doctor |
Warnings
Warnings:
Ask a doctor before use if you have
■ cough that occurs with too much phlegm (mucus)
■ cough that lasts or is chronic, such as occurs with smoking, asthma,
Chronic bronchitis, or emphysema
Stop use and ask a doctor if cough lasts more than 7 days, comes
back, or is accompanied by fever, rash or persistent headache.
These could be signs of a serious condition.
If pregnant of breast-feeding, ask a health professional before
use. Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control Center right away.
Inactive Ingredient
Inactive Ingredients: Citric Acid, Flavor, Methylparaben, Monoammonium Glycyrrhizinate, Potassium Citrate, Propylene Glycol, Propylparaben, Purified Water, Sorbitol, Sucralose
Indications & Usage
Uses:
■ helps loosen phlegm (mucus) and thin bronchial secretions to make
coughs more productive
Otc - Keep Out Of Reach Of Children
Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control Center right away.
Otc - Purpose
Purpose: Expectorant
Otc - Active Ingredient
Active Ingredient (in each 5 mL tsp)
Guaifenesin 100 mg
* Please review the disclaimer below.